We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock

Delisted

MDVL was delisted on the 12th of February, 2024.

6 hedge funds and large institutions have $202K invested in MedAvail Holdings, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more capital invested

Capital invested by funds: $145K → $202K (+$57K)

20% more funds holding

Funds holding: 56 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$36.5K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.54K
2
Morgan Stanley
Morgan Stanley
New York
-$1.7K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$119K
Citadel Advisors
2
Citadel Advisors
Florida
$38K +$36.5K +43 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$33K
Morgan Stanley
4
Morgan Stanley
New York
$8K -$1.7K -2 -18%
UBS Group
5
UBS Group
Switzerland
$4K -$2.54K -3 -38%

MDVL Hedge Fund Activity: Q2 2018 in Review

6 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2018, worth a combined $202K — up 39% from $145K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MDVL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $36.5K. The largest seller was UBS Group, cutting an estimated $2.54K.

  • 6 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2018, up from 5 in Q1 2018.
  • Funds reported $202K of MedAvail Holdings, Inc. Common Stock stock for Q2 2018, up 39% quarter-over-quarter.
  • 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +1 holder.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2018 was Citadel Advisors, an estimated $36.5K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2018 was UBS Group, an estimated $2.54K sold.

Based on aggregated 13F filings for Q2 2018.